World-first type 1 diabetes risk screening study in adults opens for recruitment

A world-first research programme led by the University of Bristol that will identify adults at high risk of developing type 1 diabetes opens for recruitment.

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress – Biotech Investments

Issuer: CureVac / Key word(s): Conference/Study 09.09.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Present First

September 10, 2024

J&J-backed Bright Peak secures $90m to advance immunoconjugate programme – Pharmaceutical Technology

Along with advancing BPT567, Bright Peak said the funds will go towards accelerating its wider pipeline. Image credit: Shutterstock / SFIO CRACHO. Bright Peak Therapeutics

June 11, 2024

Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs

Anticipation may be high that Medicare can wring lower prices out of drugmakers, but a handful of states are moving aggressively to slash costs for

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.